Vietnam has been one of the fastest-growing economies in Asia in recent years, and Sanofi has just cut a deal to give it a stronger position in the market.

With Mitsubishi Tanabe deal, Sun Pharma takes a basket of new meds into Japan, a market where Indian drugmakers are under-represented.

Chairman Zhou Jie resigns just three months after taking on the role.

By selling its Wako chemicals unit, the top Japanese drugmaker Takeda could raise $1 billion for reinvestment in its pipeline.

Sanofi provided insight into the logistics hurdles faced by vaccine makers in China after a distribution and sales rule changed.

China's Shanghai Fosun Pharmaceuticals has reportedly won a bidding war for India's privately held injectable maker Gland Pharma in a rare cross-…

Exceptions on 15 ingredients from a banned plant run by China's Zhejiang Hisun Pharmaceuticals have raised questions on the ability of inspectors to…

China Resources has teamed up with Australian investment bank Macquarie to buy a majority of cancer and cardio medical care provider GenesisCare in a $1.3…